查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1582704

全球非侵入性产前检测 (NIPT) 市场：产业分析、规模、占有率、成长、趋势和预测 (2024-2033)

Non-invasive Prenatal Testing (NIPT) Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 136 Pages | 商品交期: 2-5个工作天内

价格
简介目录

本报告调查了全球无创产前检测（NIPT）市场，并提供了市场定义和概述、市场促进和阻碍因素、各种趋势、市场机会、课题、市场规模趋势，它总结了预测，详细分析了各种细分市场/地区/主要国家、竞争环境、主要公司概况等。

主要的洞察

目录

第 1 章执行摘要

第二章市场概述

  • 市场定义
  • 市场分类

第三章全球非侵入性产前检测市场分析情境

  • 价格分析
  • 市场/预测
    • 市场规模/年成长率
  • 市场概览

第 4 章市场动态

  • 宏观经济因素
  • 促进因素
  • 阻碍因素
  • 成长机会
  • 趋势
  • 监管场景
  • 兑换场景
  • 产物比较矩阵
  • 阳性预测值比较

第五章全球无创产前检测市场分析与预测：通过测试

  • BPS 分析
  • 年成长预测
  • 市场规模预测
    • 第 1 组检查
    • 第 2 组检查
    • 第 3 组检查
  • 市场吸引力

第六章全球非侵入性产前检测市场分析与预测：依最终用户划分

  • BPS 分析
  • 年成长预测
  • 市场规模预测
    • 医院
    • 诊断实验室
    • 妇产中心
  • 市场吸引力

第七章全球非侵入性产前检测市场分析及预测：分地区

  • BPS 分析
  • 年成长预测
  • 市场规模预测
    • 北美
    • 拉丁美洲
    • 欧洲
    • 亚太地区
    • 中东/非洲
  • 市场吸引力

第八章北美非侵入性产前检测市场分析及预测

  • 市场规模预测：通过测试
  • 市场规模预测：依最终用户划分
  • 市场规模预测：依国家划分
  • 市场吸引力分析
  • 显着趋势

第九章拉丁美洲无创产前检测市场分析与预测

  • 市场规模预测：通过测试
  • 市场规模预测：依最终用户划分
  • 市场规模预测：依国家划分
  • 市场吸引力分析
  • 显着趋势

第十章欧洲无创产前检测市场分析与预测

  • 市场规模预测：通过测试
  • 市场规模预测：依最终用户划分
  • 市场规模预测：依国家划分
  • 市场吸引力分析
  • 显着趋势

第11章亚太地区非侵入性产前检测市场分析及预测

  • 市场规模预测：通过测试
  • 市场规模预测：依最终用户划分
  • 市场规模预测：依国家划分
  • 市场吸引力分析
  • 显着趋势

第十二章中东及非洲非侵入性产前检测市场分析及预测

  • 市场规模预测：通过测试
  • 市场规模预测：依最终用户划分
  • 市场规模预测：依国家划分
  • 市场吸引力分析
  • 显着趋势

第十三章竞争态势

  • 竞争对手仪表板
  • 公司简介
    • Ariosa Diagnostics, Inc.
    • Berry Genomics Co. Ltd.
    • BGI Diagnostics
    • Illumina, Inc.
    • LifeCodexx AG
    • Natera, Inc.
    • Sequenom Laboratories
    • Quest Diagnostics, Inc.

第 14 章假设/缩写

第十五章研究方法

简介目录
Product Code: PMRREP11218

Persistence Market Research has recently released a comprehensive report on the global Non-invasive Prenatal Testing (NIPT) market. This report provides an in-depth evaluation of critical market dynamics, including drivers, trends, opportunities, and challenges, delivering detailed insights into the market structure.

Key Insights:

  • NIPT Market Size (2024E): USD 7.1 Bn
  • Projected Market Value (2031F): USD 16.2 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 12.5%

NIPT Market - Report Scope:

Non-invasive prenatal testing (NIPT) is a revolutionary technology used in prenatal screening for detecting chromosomal abnormalities in a fetus. Unlike invasive testing methods, NIPT uses cell-free fetal DNA (cffDNA) from the mother's blood, providing accurate results with minimal risk. This technology is essential for expectant mothers and healthcare providers, offering early insights into genetic abnormalities such as Down syndrome, Edwards syndrome, and Patau syndrome. The NIPT market caters to diagnostic laboratories, hospitals, clinics, and various healthcare institutions, with growth fueled by increasing awareness of genetic disorders, advances in testing technology, and a rising preference for early non-invasive diagnostics.

Market Growth Drivers:

The global NIPT market is driven by several key factors. Increasing awareness of genetic disorders, especially among expectant parents, is a significant growth catalyst. Advances in DNA sequencing technology and the availability of high-accuracy screening are increasing the adoption of NIPT. Additionally, the demand for safe, non-invasive prenatal screening continues to grow as more healthcare providers advocate for early detection of chromosomal abnormalities. The rising maternal age and associated risk of genetic disorders also contribute to the increased utilization of NIPT services, while the advancements in AI and bioinformatics improve the precision and reliability of testing.

Market Restraints:

While the NIPT market shows promising growth, it faces challenges such as high test costs and limited insurance coverage in certain regions, which can impact accessibility for a broader population. Regulatory constraints in specific countries and ethical concerns regarding genetic testing also limit market expansion. Moreover, false-positive and false-negative results, though rare, may raise concerns regarding test accuracy. Addressing these challenges requires industry players to focus on cost-effective testing solutions, raise awareness of the safety and efficacy of NIPT, and work closely with policymakers to establish clear regulatory guidelines for market entry.

Market Opportunities:

The NIPT market presents notable opportunities fueled by ongoing research and technological advancements. Increasing R&D investments, especially in high-sensitivity and specific testing methods, offer potential for new product development and market expansion. The market is also likely to benefit from greater integration of NIPT with genetic counseling services, providing a holistic approach to prenatal care. Expanding NIPT into emerging markets, where demand is growing for modern healthcare solutions, also presents a significant growth area. Strategic partnerships with insurance companies, hospitals, and research institutions can further enhance market penetration and create new revenue streams.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the global NIPT market?
  • Which regions are witnessing the fastest adoption of NIPT solutions?
  • How do technological advancements influence the competitive landscape of the NIPT market?
  • Who are the leading players in the NIPT market, and what are their key strategies?
  • What are the emerging trends and future prospects in the global NIPT market?

Competitive Intelligence and Business Strategy:

Leading players in the global NIPT market, including Illumina Inc., Natera Inc., and Roche Diagnostics, focus on continuous innovation and strategic partnerships to maintain a competitive edge. These companies invest heavily in R&D to enhance the accuracy and reduce the cost of NIPT solutions. Strategic collaborations with healthcare providers and institutions strengthen market accessibility and foster product adoption. Emphasis on clinical trials, regulatory approvals, and sustainable marketing strategies also contributes to market growth and builds consumer confidence in the safety and efficacy of NIPT.

Key Companies Profiled:

  • Ariosa Diagnostics, Inc.
  • Berry Genomics Co. Ltd.
  • BGI Diagnostics
  • Illumina, Inc.
  • LifeCodexx AG
  • Natera, Inc.
  • Sequenom Laboratories
  • Quest Diagnostics, Inc.
  • Others

Non-invasive Prenatal Testing (NIPT) Market Industry Segmentation:

By Test Type

  • Panel 1 Tests
  • Panel 2 Tests
  • Panel 3 Tests

By End User

  • Hospitals
  • Diagnostic Centers
  • Maternity Clinics

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Table of Contents

1. Executive Summary

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy

3. Global Non-Invasive Prenatal Testing Market Analysis Scenario

  • 3.1. Pricing Analysis
    • 3.1.1. Pricing Assumptions
    • 3.1.2. Price Projections Per Region
  • 3.2. Market Size (US$ Mn) and Forecast
    • 3.2.1. Market Size and Y-o-Y Growth
    • 3.2.2. Absolute $ Opportunity
  • 3.3. Market Overview
    • 3.3.1. Testing Decision Flow Chart

4. Market Dynamics

  • 4.1. Macro-economic Factors
  • 4.2. Drivers
    • 4.2.1. Supply Side
    • 4.2.2. Demand Side
  • 4.3. Restraints
  • 4.4. Growth Opportunities
  • 4.5. Trends
  • 4.6. Regulatory Scenario
  • 4.7. Reimbursement Scenario
  • 4.8. Product Comparison Matrix
  • 4.9. Positive Predictive Value (PPV) Comparison

5. Global Non-Invasive Prenatal Testing Market Analysis and Forecasts, By Test

  • 5.1. Introduction
  • 5.2. Basis Point Share (BPS) Analysis By Test Type
  • 5.3. Y-o-Y Growth Projections By Test Type
  • 5.4. Market Value Forecast By Test, 2024-2033
    • 5.4.1. Panel 1 Test
    • 5.4.2. Panel 2 Test
    • 5.4.3. Panel 3 Test
  • 5.5. Market Attractiveness By Test

6. Global Non-Invasive Prenatal Testing Market Analysis and Forecasts, By End User

  • 6.1. Introduction
  • 6.2. Basis Point Share (BPS) Analysis By End User
  • 6.3. Y-o-Y Growth Projections By End User
  • 6.4. Market Value Forecast By End User, 2024-2033
    • 6.4.1. Hospitals
    • 6.4.2. Diagnostic Laboratories
    • 6.4.3. Maternity Centers
  • 6.5. Market Attractiveness By End User

7. Global Non-Invasive Prenatal Testing Market Analysis and Forecasts, By Region

  • 7.1. Basis Point Share (BPS) Analysis By Region
  • 7.2. Y-o-Y Growth Projections By Region
  • 7.3. Market Value Forecast By Region
    • 7.3.1. North America
    • 7.3.2. Latin America
    • 7.3.3. Europe
    • 7.3.4. Asia Pacific
    • 7.3.5. Middle East and Africa
  • 7.4. Market Attractiveness By Region

8. North America Non-Invasive Prenatal Testing Market Analysis and Forecast

  • 8.1. Introduction
    • 8.1.1. Basis Point Share (BPS) Analysis By Country
    • 8.1.2. Y-o-Y Growth Projections By Country
  • 8.2. Market Value Forecast By Test, 2024-2033
    • 8.2.1. Panel 1 Test
    • 8.2.2. Panel 2 Test
    • 8.2.3. Panel 3 Test
  • 8.3. Market Value Forecast By End User, 2024-2033
    • 8.3.1. Hospitals
    • 8.3.2. Diagnostic Laboratories
    • 8.3.3. Maternity Centers
  • 8.4. Market Value Forecast By Country, 2024-2033
    • 8.4.1. US
    • 8.4.2. Canada
  • 8.5. Market Attractiveness Analysis
    • 8.5.1. By Test
    • 8.5.2. By End User
    • 8.5.3. By Country
  • 8.6. Prominent Trends

9. Latin America Non-Invasive Prenatal Testing Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Basis Point Share (BPS) Analysis By Country
    • 9.1.2. Y-o-Y Growth Projections By Country
  • 9.2. Market Value Forecast By Test, 2024-2033
    • 9.2.1. Panel 1 Test
    • 9.2.2. Panel 2 Test
    • 9.2.3. Panel 3 Test
  • 9.3. Market Value Forecast By End User, 2024-2033
    • 9.3.1. Hospitals
    • 9.3.2. Diagnostic Laboratories
    • 9.3.3. Maternity Centers
  • 9.4. Market Value Forecast By Country, 2024-2033
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Test
    • 9.5.2. By End User
    • 9.5.3. By Country
  • 9.6. Prominent Trends

10. Europe Non-Invasive Prenatal Testing Market Analysis and Forecast

  • 10.1.Introduction
    • 10.1.1. Basis Point Share (BPS) Analysis By Country
    • 10.1.2. Y-o-Y Growth Projections By Country
  • 10.2.Market Value Forecast By Test, 2024-2033
    • 10.2.1. Panel 1 Test
    • 10.2.2. Panel 2 Test
    • 10.2.3. Panel 3 Test
  • 10.3.Market Value Forecast By End User, 2024-2033
    • 10.3.1. Hospitals
    • 10.3.2. Diagnostic Laboratories
    • 10.3.3. Maternity Centers
  • 10.4.Market Value Forecast By Country, 2024-2033
    • 10.4.1. UK
    • 10.4.2. France
    • 10.4.3. Germany
    • 10.4.4. Spain
    • 10.4.5. Russia
    • 10.4.6. Italy
    • 10.4.7. Rest of Europe
  • 10.5.Market Attractiveness Analysis
    • 10.5.1. By Test
    • 10.5.2. By End User
    • 10.5.3. By Country
  • 10.6. Prominent Trends

11. Asia Pacific Non-Invasive Prenatal Testing Market Analysis and Forecast

  • 11.1.Introduction
    • 11.1.1. Basis Point Share (BPS) Analysis By Country
    • 11.1.2. Y-o-Y Growth Projections By Country
  • 11.2.Market Value Forecast By Test, 2024-2033
    • 11.2.1. Panel 1 Test
    • 11.2.2. Panel 2 Test
    • 11.2.3. Panel 3 Test
  • 11.3.Market Value Forecast By End User, 2024-2033
    • 11.3.1. Hospitals
    • 11.3.2. Diagnostic Laboratories
    • 11.3.3. Maternity Centers
  • 11.4.Market Value Forecast By Country, 2024-2033
    • 11.4.1. Japan
    • 11.4.2. China
    • 11.4.3. India
    • 11.4.4. Australia & New Zealand
    • 11.4.5. ASEAN
    • 11.4.6. Rest of APAC
  • 11.5.Market Attractiveness Analysis
    • 11.5.1. By Test
    • 11.5.2. By End User
    • 11.5.3. By Country
  • 11.6. Prominent Trends

12. Middle East and Africa Non-Invasive Prenatal Testing Market Analysis and Forecast

  • 12.1.Introduction
    • 12.1.1. Basis Point Share (BPS) Analysis By Country
    • 12.1.2. Y-o-Y Growth Projections By Country
  • 12.2.Market Value Forecast By Test, 2024-2033
    • 12.2.1. Panel 1 Test
    • 12.2.2. Panel 2 Test
    • 12.2.3. Panel 3 Test
  • 12.3.Market Value Forecast By End User, 2024-2033
    • 12.3.1. Hospitals
    • 12.3.2. Diagnostic Laboratories
    • 12.3.3. Maternity Centers
  • 12.4.Market Value Forecast By Country, 2024-2033
    • 12.4.1. GCC Countries
    • 12.4.2. South Africa
    • 12.4.3. Rest of MEA
  • 12.5.Market Attractiveness Analysis
    • 12.5.1. By Test
    • 12.5.2. By End User
    • 12.5.3. By Country
  • 12.6. Prominent Trends

13. Competition Landscape

  • 13.1. Competition Dashboard
  • 13.2. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.2.1. Ariosa Diagnostics, Inc.
    • 13.2.2. Berry Genomics Co. Ltd.
    • 13.2.3. BGI Diagnostics
    • 13.2.4. Illumina, Inc.
    • 13.2.5. LifeCodexx AG
    • 13.2.6. Natera, Inc.
    • 13.2.7. Sequenom Laboratories
    • 13.2.8. Quest Diagnostics, Inc.

14. Assumptions and Acronyms Used

15. Research Methodology